Legal News

Life Sciences weekly highlights—23 February 2023

Published on: 23 February 2023
imgtext

Article summary

This week's edition of Life Sciences weekly highlights includes analysis of the upcoming key Life Sciences developments for 2023 by Lincoln Tsang and Hannah Kerr-Peterson at Ropes & Gray and analysis by Paul Abbott at Freshfields of Pfizer’s latest setback to amend its defence to limit damages in the Lyrica damages inquiry of Dr Reddy’s v Warner-Lambert, as well as, news that the European Parliament has adopted amending legislation to extend the transition periods for certain medical devices and stop the sell-off date provision delaying full application of the MDR and IVDR legislation, the MDCG has released new medical device vigilance guidance, Lord James O’Shaughnessy has been appointed to lead an independent review into clinical trials in the UK, the Commission released its report on compulsory licensing of intellectual property rights and a separate EMA report and Joint Research Centre (JRC) report reveal lessons learned from the pandemic, among other stories.

Popular documents